Chikungunya virus E1 protein (A226V mutant) (30-1943)
Recombinant Chikungunya virus E1 protein - A266V mutant
Overview
Overview
| Synonyms | Chikungunya virus E1 antigen, A226V mutant Chikungunya E1 antigen, Mutant Chikungunya virus protein, Chikungunya virus envelope protein, A226V mutant Chikungunya protein, Chikungunya antigen, CHIKV protein |
|---|---|
| Species | Viral |
| Protein Type | Recombinant |
| Applications | ELISA, Lateral Flow, SDS-PAGE |
Specifications
| Expression System | Sf-9 insect cells |
|---|---|
| Grade & Purity | > 95% pure |
| Method of Purification | Chikungunya virus E1 antigen (A226V mutant) was purified by a proprietary affinity chromatography method. |
| Form & Buffer | Supplied in liquid form in PBS buffer, pH 7.4 |
Storage & Safety
| Storage | Aliquot and store at -20 deg C. Avoid repeated freeze thaw cycles. |
|---|
General Information
| Biological Significance | Chikungunya virus is transmitted from human to human by the bites of infected female mosquitoes. Most commonly, the mosquitoes involved are Aedes aegypti and Aedes albopictus, two species which can also transmit other mosquito-borne viruses, including dengue. Chikungunya has been identified in over 60 countries in Asia, Africa, Europe and the Americas. |
|---|---|
| Implications in Disease | Chikungunya is characterized by an abrupt onset of fever frequently accompanied by joint pain. Other common signs and symptoms include muscle pain, headache, nausea, fatigue and rash. The joint pain is often very debilitating, but usually lasts for a few days or may be prolonged to weeks. |
Reviews
You need to be logged in to write a review. Please login here
Sorry there are currently no reviews for this product